Hemodialysis and vascular access system

- Hemosphere, Inc.

A hemodialysis and vascular access system comprises a subcutaneous composite PTFE silastic arteriovenous fistula having an indwelling silastic venous end which is inserted percutaneously into a vein and a PTFE arterial end which is anastomosed to an artery. Access to a blood stream within the system is gained by direct puncture of needle(s) into a needle receiving site having a tubular passage within a metal or plastic frame and a silicone upper surface through which needle(s) are inserted. In an alternate embodiment of the invention, percutaneous access to a blood stream may be gained by placing needles directly into the system (i.e. into the PTFE arterial end). The invention also proposes an additional embodiment having an arterialized indwelling venous catheter where blood flows from an artery through a tube and a port into an arterial reservoir and is returned to a vein via a port and a venous outlet tube distinct and distant from the area where the blood from the artery enters the arterial reservoir. The site where blood is returned to the vein is not directly fixed to the venous wall but is free floating within the vein. This system provides a hemodialysis and venous access graft which has superior longevity and performance, is easier to implant and is much more user friendly.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

This application is a CONTINUATION REISSUE APPLICATION of U.S. application Ser. No. 10/219,998 now U.S. Pat. No. Re. 41,448, which is a REISSUE APPLICATIONS of U.S. Pat. No. 6,102,884, which issued on Aug. 15, 2000, and which claims benefit under 35 U.S.C. Section 119(e) to U.S. Application No. 60/037,094, filed on Feb. 3, 1997, all of which are incorporated herein by reference in their entirety.

Notice: More than one reissue application has been filed for the reissue of U.S. Pat. No. 6,102,884. The reissue applications include this application, U.S. application Ser. No. 11/417,658, and U.S. application Ser. No. 10/219,998. This application is a CONTINUATION REISSUE APPLICATON of Ser. No. 10/219,998, which is a REISSUE APPLICATION of U.S. Pat. No. 6,102,884.

BACKGROUND OF THE INVENTION

Currently, HD (hemodialysis) and vascular access for chemotherapy and plasmapheresis is achieved in one of several ways. Applicant's invention involves a new method and instrumentation for HD and vascular access designed to eliminate the problems of the prior methods and create a new, more durable, easier to use, vascular access system.

One prior art method involves a primary arteriovenous fistula. In this method, a native artery is sewn to a native vein creating a high flow system of blood in a vein which over time can be accessed with two hemodialysis needles attached to a dialysis machine. The problem with this method is that few patients are candidates secondary to anatomy and in others the veins or shunt fail to enlarge and mature properly even if the primary fistula remains patent. These arteriovenous fistulas also become aneursymol over time requiring revision.

Another method involves a subcutaneous prosthetic conduit (PTFE) in the shape of a tube which is sewn at either end to openings made in an artery and vein. This method causes recurrent stenosis at the venous outflow leading to thrombosis (i.e., graft closure) secondary to intimal hyperplasia at venous anastomosis. Thrombosis also occurs at needle puncture sites along the PTFE.

Another method involves a “tunneled” percutaneous dual lumen catheter which is inserted into a central vein. This causes recurrent thrombosis secondary to stasis of blood in the lumen (i.e., not a continuous flow system like an A-V fistula) and build up of fibrinous debris at the venous end. Further, the access end of the catheter protrudes through the skin making it cosmetically unappealing, cumbersome to live with, as well as more likely to become infected.

A further method involves the use of the Sorenson Catheter. This is a percutaneous (not tunneled) dual lumen catheter, placed into the central venous system, which is used to provide temporary access for the purposes of hemodialysis. These catheters are prone to kinking, clotting, infection, and poor flow rates.

A still further method of vascular access involves the “Porta-a-cath”. This system of venous access, which utilizes a subcutaneous reservoir attached to a central venous catheter, is used for long term intervenous access for chemotherapy etc. (It is not intended for HD.) The ports are prone to clotting and must be continually flushed since they are a stagnant system.

Applicant's invention involves a vascular access system, known as the Squitieri Hemodialysis and Vascular Access System, which creates a continuous blood flow and which is easily accessed and resistant to clotting. These advantages provide ideal access for long term HD, chemo or blood draws. An example, would be patients who are on coumadin which require weekly blood draws. This new system becomes less painful over time as the skin over the “needle access” site become less sensitive. The veins are spared repeated blood draws which results in vein thrombosis to such a degree that some patients “have no veins left” making routine blood draws impossible.

Among the more relevant prior art patents are U.S. Pat. Nos. 4,898,669; 4,822,341; 5,041,098; and, 4,790,826. None of the foregoing patents disclose a system having the features of this inventions

SUMMARY OF THE INVENTION

A hemodialysis and vascular access system comprises a PTFE end which is sutured to an opening in an artery at one end and the other end is placed into a vein using any technique which avoids the need for an anastomosis between the silicone “venous” end of the catheter and the vein wall. The system comprises any material, synthetic or natural (i.e. vein) which can be sutured to the artery (i.e. preferably PTFE) at one end while the other end is composed of a material which is suitable for placement into a vein in such a way that the openings in the “venous” end of the system are away from the site where the graft enters the vein. The system may also be constructed of multiple layers of materials i.e. PTFE on the inside with silastic on the outside. The “Needle Receiving Site” may also be covered with PTFE to encourage self sealing and tissue ingrowth.

A preferred embodiment comprises a combination of PTFE conduit sewn to an artery on one end of the system with the other end connected to a silastic-plastic catheter which can be percutaneously inserted into a vein via an introducer. The venous end may also be placed via open cut down. The seal around the system where it enters the vein may be “self sealing” when placed in percutaneous technique; it may be achieved with a purse string when done by open technique “cut down”; or, it may be sewn to the vein to create a seal with a “cuff” while the system continues downstream within the venous system to return the arterial blood away from the site of entry into the vein. The entire system can be positioned subcutaneously at the completion of insertion. This design is a significant improvement over existing methods because it avoids the most frequent complication of current HD access methods. By utilizing an indwelling venous end, one avoids creating a sewn anastomosis on a vein which is prone to stenosis secondary to neointimal hyperplasia. By having continuous flow through the silastic end of the catheter, thrombosis of these catheters can be avoided. Dialysis is made more efficient by decreasing recirculation of blood which accompanies the use of side by side dual lumen catheters inserted into a central vein. This invention not only benefits the patient but it also speeds dialysis thus saving time and money.

To summarize, the Squitieri Access System comprises a tube composed of PTFE and a silastic catheter. This tube is used to create an arteriovenous fistula. The PTFE end (arterial end) of the tube is sewn to an artery while the silastic catheter end is placed into the venous system by the Seldinger technique much like a standard central line. The entire system is subcutaneous at the completion of insertion. This system is a composite of the arterial end of a “gortex graft” joined to the venous end of a “permacath”. This system enjoys strengths of each type of access and at the same time avoids their weaknesses.

Accordingly, an object of this invention is to provide a new and improved vascular access system.

Another object of this invention is to provide a new and improved hemodialysis and vascular access system including an easily replaceable needle receiving site which has superior longevity and performance, is more easily implanted, more easily replaced, and is “user friendly” i.e. easily and safely accessed by a nurse or patient which is ideal for home hemodialysis.

A more specific object of this invention is to provide a new and improved Squitieri hemodialysis and vascular access system including a subcutaneous composite PTFE/Silastic arteriovenous fistula.

A further object of this invention is to provide a new and improved hemodialysis and vascular access system including a fistula utilizing an indwelling silastic end which is inserted percutaneously into the venous system and a PTFE arterial end which is anastomosed to an artery and including a unique needle receiving sites which are positioned anywhere between the ends and which have superior longevity and performance.

A further object of this invention is to provide a system constructed to preserve laminar flow within the system and at the venous outflow end to reduce turbulence and shear force in the vascular system to the degree possible.

A still further object of this invention is to provide a system wherein the arterial end (PTFE) may also be placed by percutaneous technique including one where blood entry holes are distant from the site where blood enters the veins.

BRIEF DESCRIPTION OF THE DRAWINGS

The above and other objects of this invention may be more clearly seen when viewed in conjunction with the accompanying drawings wherein:

FIG. 1 is a perspective view of the vascular access system comprising the invention;

FIG. 2 is a cross-sectional view of the needle access site taken along the line 2-2 of FIG. 1;

FIG. 3 is a cross-sectional view similar to FIG. 2 with a needle inserted into the access site;

FIG. 4 is a cross-sectional view of the coupling between the PTFE and the silicone venous end of the catheter;

FIG. 5 is a perspective view of an alternate embodiment of the invention with one port having a tube sewn to a vein;

FIG. 6 is a perspective view of the embodiment in FIG. 5 with a silastic tube floated down a vein;

FIG. 7 illustrates a ringed tube sewn to an artery and connected to a first access site which is joined to a second site by silastic tubing and includes an outflow through silastic tubing which is floated into the venous system via a neck vein, i.e., a jugular vein;

FIG. 8 is similar to FIG. 7 but shows PTFE sewn to an artery and silastic tubing floated into a different portion of the venous system;

FIG. 9 depicts ringed PTFE tubing sewn to the subclavian artery and a dual access site coupled to the venous system via a neck vein, i.e., a jugular vein, at its other end;

FIG. 10 shows a multi-layered variation at the venous end of the system;

FIG. 11 discloses a quick coupler design utilized in conjunction with the system;

FIG. 12 is a unique port design utilized in conjunction with the system;

FIG. 13 shows holes where ports can be fixed in place while FIG. 13a and FIG. 13b show cross-sectional views which depict the internal construction of the invention with FIG. 13b illustrating multi-layered tubing; and,

FIG. 14 shows a variation of the system entry through vein wall (i.e. not percutaneous or purse string) wherein a cuff, sewn to vein as indwelling portion, is floated down stream.

 DETAILED DESCRIPTION OF THE INVENTION

Referring to the drawings the Squitieri hemodialysis and vascular system, as shown in FIG. 1, comprises a PTFE/dacron (or other synthetic or natural material) tube 10 of several centimeters in length which is attached at one end by means of a coupling 11 to a needle access site 20. Adjustable band 18 regulates the blood flow through the access site 20. The PTFE tube 10 is approximately 7 mm in diameter and transitions downward to an open end portion 19 approximately 4 mm in diameter.

The access site 20 includes an in line aperture 16, see FIG. 2, having a silicone tube 41 connected thereto at one end leading to a long flexible plastic/silastic/silicone tube 12 with transverse holes 13 along its free end. The number of holes 13 may vary within predetermined limits to achieve optimum results. The end 36 may be beveled for ease of insertion. This tubular arrangement functions as a subcutaneous connection between the arterial and venous systems. It may also be modified to allow part of the system to exit through the skin 14 to provide access to the blood circulation without placing needles 15 through the skin 14 into the fistula (usually at the PTFE end).

Along the length of the catheter specially constructed access segments 20 are located to receive specially designed needles 15 into the system to gain access to the blood stream which flows through aperture 16. This method avoids perigraft bleeding which leads to thrombosis either by compression of the graft by hematoma or by manual pressure applied to the graft in an attempt to control the bleeding.

The needle access areas 20 which are designed to receive needles 15 etc. to allow access to the system are in line conduits with self-sealing material 17 such as silicone located beneath the skin surface. The silicone member 25 comprises an oval configuration exposed within the frame 26 for ease of puncture. The system may be accessed immediately after insertion without having to wait for the graft to incorporate into the tissues as is the case with the current methods of subcutaneous fistulas. These access areas 20 will protect the graft since they are uniformly and easily utilized requiring little training or experience. The “needle receiving” sites 20 are designed in such a way to preserve laminar flow as far as possible (i.e. not a reservoir arrangement). Needle receiver sites 20 may be connected to a system via “quick couple” 45 for easy exchangability, see FIG. 11.

FIGS. 2 and 3 disclose a needle access site 20 wherein a silicone member 25 is mounted within a plastic or metal frame 26. A protruding portion 27 of member 25 extends upwardly through the aperture 31 while a flange portion 28 extends outwardly on both sides of the portion 27 to be gripped by teeth 29 on the internal surface of frame 26 and member 32. The member 26 includes a passage 16 for blood flow. The blood flow is accessed by inserting needles 15 through the silicone 25 which is preferably oval in shape. The teeth 29 seal the arterial pressure. The internal chamber 16 of the needle receiving site 20 is tubular in shape.

The free end 19 of the PTFE tube 10 is sewn to an opening in an artery 30, see FIG. 7, while the plastic end 24 having been inserted percutaneously lies in the venous system in such a way that the openings 13 in the silastic tube 12 are downstream from the site where the flexible plastic tube 24 enters the vein 40. The venous end may be inserted via “cutdown”. The purpose of the system is to allow communication between an artery 30 and a vein 40 in such a way that the system may be accessed by either puncturing the PTFE segment or by entering the specialized “needle receiving” site 20. This allows blood to flow from the system to a hemodialysis machine (not shown) and then return into the venous outflow portion at a more distal (venous end) location allowing the blood 35 to return from the HD machine (not shown) back into the patient.

FIG. 4 discloses, as an alternative, a “glued” connection between PTFE tubing 60 and silicone tubing 61 wherein the PTFE 61 is inserted into an enlarged portion of silicone 61 wherein the longitudinally extending portion includes a raised section 63 which locks a raised section 64 of PTFE 61 within the silicone 60.

In this invention, the materials used may vary as specified herein. The system may be constructed of one or more specific materials. The arteries and veins used may also vary. Material may also be covered with thrombus resistant coatings (heparin, etc.) or biologic tissue. The system may in specific cases be “ringed” for support.

The same concept of using an arterialized venous access catheter may be applied to the use of long term indwelling catheters used to give chemotherapy etc., making the current ports obsolete as these new access systems will have a decreased thrombosis rate and they will no longer need to be flushed as continuous blood flow through the system makes thrombus formation unlikely. This will definitely cut down on costs since it will decrease nursing requirements in out patient settings, etc.

In alternate embodiments shown in FIGS. 5 and 6, the system comprises an arterial reservoir structure or port 50 with a needle accessible top portion 51 preferably constructed of silicone. The reservoir 50 is connected to an outlet tube 53 of PTFE (gortex-ringed), which is sewn to an artery 30 at its other end. The venous outlet tube 52 is constructed in a similar way but it is either sewn to a vein 40 via gortex ringed portion 52 or is placed percutaneously into the central circulation via an indwelling venous (silicon) catheter 42 as shown in FIG. 6. There is no continuous flow through this version of the system since the ports are not connected. Flow is established when the system is attached to an HD machine with a needle 15 in the arterial port 51a to deliver blood to the HD machine and a second needle 15 is placed in the venous port 51b to the vein 40 to deliver blood to the patient. The ports 51a, 51b will remain flushed with heparin when not in use to avoid clotting when accessed through the skin 14 with needles 15. The ports 51a, 51b will also provide high flow access to both the arterial and venous systems. FIG. 6 shows two separate ports 51a and 51b with one tube 53 sewn to an artery 30 and the other tube 42 floated down a vein 40.

FIG. 7 illustrates, in an anatomical drawing, a ringed gortex tubing an outlet tube 53 of PTFE (ringed gortex) sewn to an artery 30 at 62 and coupled at its other end 63 62a to the needle access site 20. The site 20, see FIGS. 1-3, is joined by silastic tubing 64 68 to a second access site 20a which has an outlet silastic tube 65. The outlet tube 65 includes a plurality of perforations 66 at its outlet end which is positioned in the venous system 67 through a neck vein, i.e., a jugular vein 40. Either site 20 or 20a can be used for needle access.

FIG. 8 depicts an embodiment similar to that of FIG. 7 except that the coupling between the artery 30 and the first needle access site 20 is PTFE tube 69. The entry to the venous system 67 is via vein 40 which has silastic tubing 65 floated therein. 69a depicts PTFE joining parts 20 and 20a.

FIG. 9 illustrates a dual needle access site 80 which is coupled via ringed PTFE 53 to the subclavian artery 30 and floated into the venous system 67 via silastic tubing 65. The dual site 80 provides additional access through 25a, 25b in approximately the same area with tubing (not shown) extending through the dual site 80.

FIG. 10 depicts a variation of the invention at the venous end wherein the outlet of the port 20 comprises PTFE tubing 91 located within a silastic catheter 92. This design is appropriate if thrombosis is a problem in the outlet silastic portion of the shunt.

FIG. 11 discloses a quick coupler 45 joining the PTFE tubing 53 to the port 46 in the needle access site 20. A plastic or metal member 47 includes a portion 48 which engages the cylindrical tubing 10, an intermediate portion 49 extending perpendicularly outward and an end portion 43 tapered outwardly at an angle and including an inward projection 44. The projecting portion 44 of the member 47 engages a slot 54 in the port 46 firmly fixing the PTFE 10 therebetween. 45a is made of flexible material to allow a gentle curve in tubing as it exits/enters port.

FIG. 12 is an exploded view of a new port embodiment wherein the port 71 comprises a frame 72 having an inlet 73 and an outlet 74. The plastic or metal frame 75 includes a recessed reservoir 76 and end walls 78a and 78b. An upper member 85 having a recess 86 and downwardly projecting sides 87a and 87b fits within walls 77a and 77b. The member 45 rapidly couples the PTFE tubing 10 to site 71 with tubing 88 which fits over the inlet coupling 73 and the outlet coupling 74 with recessed portions 75a and 75b which engage tubing 88a and 88b and have couplers 89a and 89b which slide over the tubing 88a, 88b to engage the couplings 73 and 74.

FIG. 13 shows a typical dual port system showing holes 55 where ports 20 can be fixed in place.

FIG. 14 discloses a cuff 56 which is made of PTFE and sewn to a vein. No physiological/functional venues anastomosis is created as blood is returned at the end of the system distant from the cuff. The silastic end 12 may still be lined with PTFE.

The upper member 86 includes an oval silicone access site 90 with an outer housing 91 which includes an aperture 92 surrounds the silicone oval 90. This embodiment provides a quick assembly for a needle access site 71.

The Squitieri Hemodialysis/Vascular Access System avoids creation of a venous anastomosis, a revolutionary advancement, i.e. there is no site for neointimal hyperplasia at a venous anastomosis which accounts for the vast majority of PTFE arteriovenous graft failures (60-80%). This is accomplished by returning the blood into a larger vein via an indwelling venous catheter 42. The site of blood return to the venous system is not fixed to the vein wall where neointimal hyperplasia occurs with the standard PTFE bridge graft. This feature represents a tremendous advantage over the present grafts.

As a further advantage, the system is not stagnant and prone to thrombosis, i.e. constant flow through the new system avoids the problem of clotting inherent in indwelling dual lumen venous catheters which remain stagnant when not in use. It also avoids need to flush catheters with heplock thereby reducing nursing costs to maintain the catheter.

The Squitieri system avoids externalization of components which are prone to infection. Since dual lumen catheters exit the skin 14, they frequently lead to sepsis requiring catheter removal despite subcutaneous tunneling. This new access is entirely subcutaneous.

Very importantly the system proposed herein, avoids problems with the aspiration of blood from the venous system and “positional” placement through continuous flow. A frequent problem with dual lumen catheters is their inability to draw blood from the venous system due to clot and fibrinous debris ball-valving at the tip of a catheter. This new system receives blood directly from arterial inflow which ensures high flow rates needed for shorter, more efficient dialysis runs. It also avoids the frequent problem of the catheter tip “sucking” on the vein wall inhibiting flow to the dialysis machine and rendering the access ineffective.

The system avoids recirculation seen with dual lumen catheters resulting in more efficient and more cost effective dialysis.

The system avoids the need for temporary access with incorporation of “Needle Access Sites” 20. A-V fistulas and gortex grafts must “mature” for several weeks before use. This creates a huge strain on the patient as well as the doctor to achieve temporary access while waiting to use the permanent access. Temporary access is very prone to infection, malfunction and vein destruction. By placing sites 20 designed to receive needles 15 along the new access, the system may be used the day it is inserted.

The system avoids PTFE needle site damage with the incorporation of “Needle Access Sites” 20. Needle access directly into PTFE is presently uncontrolled and user dependent. Often, PTFE is lacerated by access needles. While this system may be accessed via the PTFE segment, the needle receiving sites are the preferred method. This leads to excessive bleeding which requires excessive pressure to halt the bleeding causing thrombosis of the graft. “Needle Access Sites” 20 on the Squitieri access system allow safe, quick, and easy entry into the system and avoid the complications inherent in placing needles directly into PTFE. It also avoids perigraft bleeding which will compress and thrombose the graft. By eliminating the long time needed to compress bleeding at the needle site, the system shortens dialysis runs.

The Squitieri system permits an easier, faster insertion technique. Only one anastomosis at the arterial end and a percutaneous placement of the venous end is required. A modification allows the system to be sutured to the vein wall while the system tubing is floated down stream from this site where the system enters the vein 40. This saves operating room time at thousands of dollars per hour. The technique is easier with faster replacement. It avoids difficult and time consuming revision of venous anastomosis required to repair venous outflow occluded by neointimal hyperplasia. If the system malfunctions, the silastic catheter end 65 slips out easily and the arterial PTFE end 53 is thrombectomized. New access sewn to the thrombectomized PTFE at the arterial end and the silastic venous end is replaced percutaneously via Seldinger technique or “open technique”.

The end result of the above advantages translates into superior patency rates and a decreased complication rate with this new system. Patients are spared the repeated painful hospitalizations for failed access as well as the emotional trauma associated with this difficult condition. The physicians are spared the dilemma of how to best treat these patients. This system will have a large impact on the current practice of vascular access in areas such as hemodialysis; plasmapheresis; chemotherapy; hyperalimentation; and chronic blood draws.

While the invention has been explained by a detailed description of certain specific embodiments, it is understood that various modifications and substitutions can be made in any of them within the scope of the appended claims which are intended also to include equivalents of such embodiments.

Claims

1. A Squitieri hemodialysis and vascular access system to shunt blood between a vein and an artery the system comprising:

(a) a first tube having a first end adapted to be connected to the artery and a second end;
(b) a second tube having a first end adapted to be connected to the vein and including a plurality of apertures extending therethrough and having a second end; and
(c) a needle access port having a frame including a conduit extending therethrough, said frame having an inlet connected to the second end of the first tube and an outlet connected to the second end of the second tube to provide a flow path for blood and a silicone member protruding from the frame to provide access for needles into the flow path, wherein the needle access port includes: an outer frame member having an upper surface including an aperture extending therethrough and downwardly extending walls about its periphery having inlet and outlet apertures, wherein the upper surface includes a lower portion having a plurality of teeth; a silicone member mounted within the frame having a surface engaged by the frame teeth and an upwardly protruding portion extending through the frame aperture; and a second frame member having a transverse conduit extending between the inlet and outlet apertures, an upper surface having a plurality of teeth engaging the silicone member to effect a seal and wherein the second frame member is positioned within the walls of the first frame member.

2. The Squitieri hemodialysis and vascular access system of claim 1, wherein:

the first tube corresponds to PTFE tubing;
the second tube corresponds to silicone tubing; and
the protruding silicone member has an oval configuration.

3. The Squitieri hemodialysis and vascular access system of claim 1, wherein the first tube includes rings mounted thereabout to provide additional strength.

4. The Squitieri hemodialysis and vascular access system of claim 1 further comprising:

a second needle access port having an inlet and an outlet and silastic tubing coupling the inlet of the second needle access port to the outlet of the other needle access port and wherein the outlet of the second access port is coupled to the second end of the second tube.

5. The Squitieri hemodialysis and vascular access system of claim 1 wherein:

the first tube is provided as PTFE tubing which is adapted for attachment to the artery at one end and coupled to the access port at the other end; and
the second tube is provided as silicone tubing which is coupled to the needle access port at one end and is capable of being floated within the vein at the other end.

6. The Squitieri hemodialysis and vascular access system of claim 1, wherein:

the first tube is inserted within an outer silicone tubing at the inlet to the needle access port.

7. The Squitieri hemodialysis and vascular access system of claim 1, further including:

an adjustable band mounted about the first tube at the inlet to the needle access port to regulate blood flow.

8. The Squitieri hemodialysis and vascular access system of claim 4, wherein:

a second needle access port is mounted to the needle access port, said ports having a single frame and a conduit extending longitudinally therethrough to the outlet tubing.

9. A Squitieri hemodialysis and vascular access system to shunt blood between a vein and an artery, the system including:

(a) a first tube having a first end adapted to be connected to the artery;
(b) a second tube having a first end adapted to be connected to the vein and including a plurality of apertures extending therethrough and having a second end;
(c) a needle access port having a frame including a conduit extending therethrough, said frame having an inlet connected to the second end of the first tube and an outlet connected to the second end of the second tube to provide a flow path for blood and a silicone member protruding from the frame to provide access for needles into the flow path; and
a quick coupler for joining the first tube to the needle access port comprising a port member projecting outwardly from the frame inlet and having a circumferential slot extending thereabout, a cooperating member having an outer portion extending concentrically with the first tube and a portion extending outwardly therefrom and an outwardly sloped portion extending over the projecting port member and having an inner circumferential projection which engages the circumferential slot, and wherein the first tube extends over the port member to be engaged by the projecting portion of the cooperating member within the slot and a removable coupling which snaps over the cooperating member forcing it into a sealed engagement with the port member.

10. A Squitieri hemodialysis and vascular access system to shunt blood between a vein and an artery, the system including:

(a) a first tube having a first end adapted to be connected to the artery;
(b) a second tube having a first end adapted to be connected to the vein and including a plurality of apertures extending therethrough and having a second end; and
(c) a needle access port having a frame including a conduit extending therethrough, said frame having an inlet connected to the second end of the first tube and an outlet connected to the second end of the second tube to provide a flow path for blood and a silicone member protruding from the frame to provide access for needles into the flow path, wherein the needle access port comprises: a first member having a base, walls extending upwardly therefrom to form an enclosed area, and outwardly extending couplings on opposite walls thereof at the inlet and outlet of said port; a second member having a top including an upper aperture, downwardly extending side walls engaging the walls of the first member and having a conduit extending from the inlet to the outlet and a silicone member projecting form the upper aperture to provide needle access; and a tube mounted over each coupling and a coupler which fits over each tube to seal the tubes to the couplings.

11. The Squitieri hemodialysis and vascular access system of claim 1, wherein:

the second tube is capable of being floated within a vein at the one end and the plurality of apertures in the second tube are distant from the site where the second tube is inserted into the vein, said second tube not being fixed to the vein wall.

12. A hemodialysis and vascular access system comprising:

an arterialized indwelling venous catheter having a graft section provided from a material which is biocompatible with an artery, has a nonthrombogenic characteristic, which is adapted for long term attachment to an artery and which includes a region for repeated needle access and a catheter section, with a first end of said graft section adapted to be coupled to an artery and a portion of the catheter section adapted to be inserted within a vein at an insertion site, said catheter section portion having at least one opening in an end thereof with at least one of the at least one openings in the catheter section portion adapted to be within the vein itself and wherein the at least one opening is distant from the insertion site such that blood flows from the artery through the catheter and is returned to the vein through the at least one opening while providing laminar blood flow between the artery and the vein.

13. The hemodialysis and vascular access system of claim 12, further comprising:

at least one needle having a first end coupled to a hemodialysis device and having a second end adapted for insertion directly into said graft section of the catheter to shunt the blood flow through the dialysis device.

14. The hemodialysis and vascular access system of claim 13 wherein said graft section is provided from a first tube and said catheter section is provided from a second tube comprising multiple layers and a first end of said first tube is coupled to a first end of said second tube.

15. The hemodialysis and vascular access system of claim 14 wherein said first and second tubes are adapted for percutaneously placement.

16. The hemodialysis and vascular access system of claim 14 wherein the end of said second tube which is coupled to the first tube includes an enlarged portion in which the first end of said first tube is disposed.

17. A method for providing hemodialysis and vascular access, comprising:

providing an indwelling venous catheter, having: a graft section provided from a material which is biocompatible with an artery, has a nonthrombogenic characteristic, which is configured for long term attachment to an artery and which includes a first end of said graft section configured to be coupled to an artery and a region for repeated needle access; and a catheter section, with a portion of the catheter section configured to be inserted within a vein at an insertion site, said catheter section portion having at least one opening in an end thereof with at least one of the at least one openings in the catheter section portion configured to be within the vein itself;
arterializing the indwelling venous catheter by attaching the graft section to an artery to form an arterialized indwelling venous catheter;
implanting the region for repeated needle access so that it is entirely subcutaneous;
inserting the catheter section into a vein through a side wall of the vein at the insertion site, such that the at least one opening is distant from the insertion site such that blood flows from the artery through the catheter section and is returned to the vein through the at least one opening while providing laminar blood flow between the artery and the vein; and
providing continuous fluid flow between the graft section and the catheter section at least when the region for repeated needle access is not being accessed.

18. The method for providing vascular access as in claim 17, wherein the catheter and graft sections are separable components at least prior to the step of providing continuous fluid flow.

19. The method for providing vascular access as in claim 18, further comprising connecting the catheter section and the graft section using a connector.

20. The method for providing vascular access as in claim 19, wherein the connector is a quick-couple connector.

21. The method for providing vascular access as in claim 17, wherein the at least one opening is free floating within the vein.

22. The method for providing vascular access as in claim 17, further comprising percutaneously accessing the vein.

23. The method for providing vascular access as in claim 22, wherein percutaneously accessing the vein comprises accessing the vein by Seldinger technique.

24. The method for providing vascular access as in claim 17, further comprising accessing the vein using an open cut down procedure.

25. The method for providing vascular access as in claim 24, further comprising placing a purse string suture about the insertion site of the vein.

26. The method for providing vascular access as in claim 17, further comprising floating said catheter section portion downstream from the insertion site of the vein.

27. The method for providing vascular access as in claim 17, wherein the vein is a neck vein.

28. The method for providing vascular access as in claim 27, wherein inserting the catheter section into the vein comprises inserting the catheter section into the neck vein and advancing the catheter section toward the right atrium.

29. The method for providing vascular access as in claim 17, further comprising subcutaneously tunneling an implantation site for at least a portion of the indwelling venous catheter.

30. The method for providing vascular access as in claim 17, wherein the catheter section is inserted into the vein before the graft section is arterialized to the artery.

31. The method for providing vascular access as in claim 30, further comprising attaching a free end of the graft section to a wall of the artery while the end of the catheter section having been inserted in the vein in such a way that the at least one opening in the end thereof is downstream of the site where the catheter section enters the vein.

32. The method for providing vascular access as in claim 17, wherein the catheter section is not fixed to the vein wall.

33. The method for providing vascular access as in claim 17, wherein the method avoids creating a venous anastomosis.

34. The method for providing vascular access as in claim 17, wherein the catheter section comprises a long, flexible plastic tube.

35. The method for providing vascular access as in claim 34, wherein the end is beveled.

36. The method for providing vascular access as in claim 17, comprising implanting a vascular access system comprising the catheter section and the graft section and implanting the system so that is entirely subcutaneous.

37. The method for providing vascular access as in claim 17, wherein the region for repeated needle access comprises needles receiving site(s) and comprises an internal chamber that is tubular in shape.

38. The method for providing vascular access as in claim 17, wherein the region for repeated needle access comprises self sealing material.

39. The method for providing vascular access as in claim 17, wherein the graft section comprises a PTFE section.

40. The method for providing vascular access as in claim 17, wherein the catheter section comprises a silicone section.

41. The method for providing vascular access as in claim 40, wherein the silicone section is lined with PTFE.

42. The method for providing vascular access as in claim 17, wherein the region for repeated needle access comprises multiple layers.

43. The method for providing vascular access as in claim 42, wherein the multiple layers comprise PTFE on the inside and silicone on the outside.

44. The method for providing vascular access as in claim 42, wherein the multiple layers comprise PTFE on the inside and silicone disposed outside of the PTFE.

45. The method for providing vascular access as in claim 17, wherein the material providing the graft section comprises a thrombus resistant coating.

46. The method for providing vascular access as in claim 45, wherein the thrombus resistant coating comprises heparin.

47. The method for providing vascular access as in claim 17, wherein a nonthrombenic characteristic is provided by continuous flow of blood through at least the graft section.

48. The method for providing vascular access as in claim 17, wherein the vein is a jugular vein.

49. The method for providing vascular access as in claim 17, wherein arterializing further comprises attaching the graft section to a side wall of an artery such that blood can flow from the artery into the graft and can flow in the artery downstream of the point of connection to the artery.

50. A hemodialysis and vascular access system to shunt blood between a vein and an artery, the system comprising:

(a) a first tube having a first end adapted to be connected to the artery and a second end;
(b) a second tube having a first end adapted to be connected to the vein and including a plurality of apertures extending therethrough and having a second end; and
(c) a needle access port configured to be subcutaneously implantable, the needle access port having a frame including a conduit extending therethrough, said frame having an inlet connected to the second end of the first tube and an outlet connected to the second end of the second tube to provide a flow path for blood and a silicone member protruding from the frame to provide access for needles into the flow path, wherein the needle access port includes: an outer frame member having an upper surface including an aperture extending therethrough and downwardly extending walls about its periphery having inlet and outlet apertures, wherein the upper surface includes a lower portion having a plurality of teeth; a silicone member mounted within the frame having a surface engaged by the frame teeth and an upwardly protruding portion extending through the frame aperture; and a second frame member having a transverse conduit extending between the inlet and outlet apertures, an upper surface having a plurality of teeth engaging the silicone member to effect a seal and wherein the second frame member is positioned within the walls of the first frame member.

51. The hemodialysis and vascular access system of claim 50, wherein:

the first tube corresponds to PTFE tubing;
the second tube corresponds to silicone tubing; and
the protruding silicone member has an oval configuration.

52. The hemodialysis and vascular access system of claim 50, wherein the first tube includes rings mounted thereabout to provide additional strength.

53. The hemodialysis and vascular access system of claim 50, further comprising:

a second needle access port having an inlet and an outlet and silastic tubing coupling the inlet of the second needle access port to the outlet of the other needle access port and wherein the outlet of the second access port is coupled to the second end of the second tube.

54. The hemodialysis and vascular access system of claim 50, wherein:

the first tube is provided as PTFE tubing which is adapted for attachment to the artery at one end and coupled to the access port at the other end; and
the second tube is provided as silicone tubing which is coupled to the needle access port at one end and is capable of being floated within the vein at the other end.

55. The hemodialysis and vascular access system of claim 50, wherein:

the first tube is inserted within an outer silicone tubing at the inlet to the needle access port.

56. The hemodialysis and vascular access system of claim 50, further including:

an adjustable band mounted about the first tube at the inlet to the needle access port to regulate blood flow.

57. The hemodialysis and vascular access system of claim 53, wherein:

a second needle access port is mounted to the needle access port, said ports having a single frame and a conduit extending longitudinally therethrough to the outlet tubing.

58. A hemodialysis and vascular access system to shunt blood between a vein and an artery, the system including:

(a) a first tube having a first end adapted to be connected to the artery;
(b) a second tube having a first end adapted to be connected to the vein and including a plurality of apertures extending therethrough and having a second end;
(c) a needle access port configured to provide a subcutaneous connection between the first tube and the second tube, the needle access port having a frame including a conduit extending therethrough, said frame having an inlet connected to the second end of the first tube and an outlet connected to the second end of the second tube to provide a flow path for blood and a silicone member protruding from the frame to provide access for needles into the flow path; and
a quick coupler for joining the first tube to the needle access port comprising a port member projecting outwardly from the frame inlet and having a circumferential slot extending thereabout, a cooperating member having an outer portion extending concentrically with the first tube and a portion extending outwardly therefrom and an outwardly sloped portion extending over the projecting port member and having an inner circumferential projection which engages the circumferential slot, and wherein the first tube extends over the port member to be engaged by the projecting portion of the cooperating member within the slot and a removable coupling which snaps over the cooperating member forcing it into a sealed engagement with the port member.

59. A hemodialysis and vascular access system to shunt blood between a vein and an artery, the system including:

(a) a first tube having a first end adapted to be connected to the artery;
(b) a second tube having a first end adapted to be connected to the vein and including a plurality of apertures extending therethrough and having a second end; and
(c) a needle access port configured to be subcutaneously implantable, the needle access port having a frame including a conduit extending therethrough, said frame having an inlet connected to the second end of the first tube and an outlet connected to the second end of the second tube to provide a flow path for blood and a silicone member protruding from the frame to provide access for needles into the flow path, wherein the needle access port comprises: a first member having a base, walls extending upwardly therefrom to form an enclosed area, and outwardly extending couplings on opposite walls thereof at the inlet and outlet of said port; a second member having a top including an upper aperture, downwardly extending side walls engaging the walls of the first member and having a conduit extending from the inlet to the outlet and a silicone member projecting form the upper aperture to provide needle access; and a tube mounted over each coupling and a coupler which fits over each tube to seal the tubes to the couplings.

60. The hemodialysis and vascular access system of claim 59, wherein:

the second tube is capable of being floated within a vein at the one end and the plurality of apertures in the second tube are distant from the site where the second tube is inserted into the vein, said second tube not being fixed to the vein wall.
Referenced Cited
U.S. Patent Documents
3363926 January 1968 Wilson
3490438 January 1970 Stupka et al.
3683926 August 1972 Suzuki
3814137 June 1974 Martinez
3818511 June 1974 Goldberg et al.
3826257 July 1974 Buselmeier
3882862 May 1975 Berend
3998222 December 21, 1976 Shihata
4076023 February 28, 1978 Martinez
4133312 January 9, 1979 Burd
4184489 January 22, 1980 Burd
4214586 July 29, 1980 Mericle
4318401 March 9, 1982 Zimmerman
4427219 January 24, 1984 Madej
4447237 May 8, 1984 Frisch et al.
4496349 January 29, 1985 Cosentino
4496350 January 29, 1985 Cosentino
4503568 March 12, 1985 Madras
4550447 November 5, 1985 Seiler, Jr.
4619641 October 28, 1986 Schanzer
4655771 April 7, 1987 Wallsten
4734094 March 29, 1988 Jacob et al.
4753236 June 28, 1988 Healey
4771777 September 20, 1988 Horzewski et al.
4772268 September 20, 1988 Bates
4786345 November 22, 1988 Wood
4790826 December 13, 1988 Elftman
4822341 April 18, 1989 Colone
4848343 July 18, 1989 Wallsten et al.
4850999 July 25, 1989 Planck
4856938 August 15, 1989 Kuehn
4877661 October 31, 1989 House et al.
4898669 February 6, 1990 Tesio
4917067 April 17, 1990 Yoshida
4917087 April 17, 1990 Walsh et al.
4919127 April 24, 1990 Pell
4929236 May 29, 1990 Sampson
4955899 September 11, 1990 Della Corna et al.
5026513 June 25, 1991 House et al.
5041098 August 20, 1991 Loiterman et al.
5053023 October 1, 1991 Martin
5061275 October 29, 1991 Wallsten et al.
5061276 October 29, 1991 Tu et al.
5064435 November 12, 1991 Porter
5104402 April 14, 1992 Melbin
5171227 December 15, 1992 Twardowski et al.
5171305 December 15, 1992 Schickling et al.
5192289 March 9, 1993 Jessen
5192310 March 9, 1993 Herweck et al.
5197976 March 30, 1993 Herweck et al.
5330500 July 19, 1994 Song
5399168 March 21, 1995 Wadsworth, Jr. et al.
5405320 April 11, 1995 Twardowski et al.
5405339 April 11, 1995 Kohnen et al.
5454790 October 3, 1995 Dubrul
5476451 December 19, 1995 Ensminger et al.
5496294 March 5, 1996 Hergenrother et al.
5509897 April 23, 1996 Twardowski et al.
5558641 September 24, 1996 Glantz et al.
5562617 October 8, 1996 Finch, Jr. et al.
5562618 October 8, 1996 Cai et al.
5591226 January 7, 1997 Trerotola et al.
5607463 March 4, 1997 Schwartz et al.
5624413 April 29, 1997 Markel et al.
5631748 May 20, 1997 Harrington
5637088 June 10, 1997 Wenner et al.
5637102 June 10, 1997 Tolkoff et al.
5647855 July 15, 1997 Trooskin
5669637 September 23, 1997 Chitty et al.
5669881 September 23, 1997 Dunshee
5674272 October 7, 1997 Bush et al.
5676346 October 14, 1997 Leinsing
5743894 April 28, 1998 Swisher
5755773 May 26, 1998 Evans et al.
5755775 May 26, 1998 Trerotola et al.
5792104 August 11, 1998 Speckman et al.
5797879 August 25, 1998 DeCampli
5800512 September 1, 1998 Lentz et al.
5800514 September 1, 1998 Nunez et al.
5800522 September 1, 1998 Campbell et al.
5810870 September 22, 1998 Myers et al.
5829487 November 3, 1998 Thomas et al.
5830224 November 3, 1998 Cohn et al.
5840240 November 24, 1998 Stenoien et al.
5866217 February 2, 1999 Stenoien et al.
5904967 May 18, 1999 Ezaki et al.
5931829 August 3, 1999 Burbank et al.
5931865 August 3, 1999 Silverman et al.
5957974 September 28, 1999 Thompson et al.
5997562 December 7, 1999 Zadno-Azizi
6001125 December 14, 1999 Golds et al.
6019788 February 1, 2000 Butters et al.
6036724 March 14, 2000 Lentz et al.
6102884 August 15, 2000 Squitieri
6156016 December 5, 2000 Maginot
6167765 January 2, 2001 Weitzel
6261255 July 17, 2001 Mullis et al.
6338724 January 15, 2002 Dossa
6398764 June 4, 2002 Finch et al.
6402767 June 11, 2002 Nash et al.
6428571 August 6, 2002 Lentz et al.
6582409 June 24, 2003 Squitieri
6702781 March 9, 2004 Reifart et al.
6719781 April 13, 2004 Kim
6719783 April 13, 2004 Lentz et al.
6730096 May 4, 2004 Basta
7025741 April 11, 2006 Cull
RE41448 July 20, 2010 Squitieri
20020049403 April 25, 2002 Alanis
20030004559 January 2, 2003 Lentz et al.
20040193242 September 30, 2004 Lentz et al.
20040215337 October 28, 2004 Hain et al.
20050137614 June 23, 2005 Porter et al.
20050203457 September 15, 2005 Smego
20050215938 September 29, 2005 Khan et al.
20060064159 March 23, 2006 Porter et al.
20070123811 May 31, 2007 Squitieri
20070167901 July 19, 2007 Herrig et al.
Foreign Patent Documents
4418910 July 1995 DE
44 18 910 December 1995 DE
295 15 546 March 1997 DE
57-14358 January 1982 JP
58-168333 November 1983 JP
62-112567 May 1987 JP
04-507050 December 1992 JP
05-212107 August 1993 JP
06-105798 April 1994 JP
09-84871 March 1997 JP
WO 84/03036 August 1984 WO
WO 95/19200 July 1995 WO
WO 96/24399 August 1996 WO
Other references
  • U.S. Appl. No. 08/835,316 including its prosecution history and U.S. Appl. No. 10/219,998: Prosecution Events: Office Actions: May 9, 2003; Apr. 27, 2004; Oct. 19; 2004; Apr. 9, 2007; Oct. 7, 2008; Mar. 23, 2010; Amendments: Nov. 10, 2003; Aug. 30, 2004; Jan. 31, 2005; May 23, 2005; Sep. 10, 2007; Nov. 3, 2008; Jun. 16, 2009.
  • U.S. Appl. No. 10/962,200 and its prosecution history including the Office Actions mailed Feb. 14, 2007, Jun. 11, 2007, Nov. 26, 2007, Nov. 26, 2007, Aug. 12, 2009, Dec. 17, 2009, May 5, 2010 and the Amendments filed Mar. 13, 2007, Jul. 27, 2007, Feb. 26, 2008, Jan. 12, 2010.
  • U.S. Appl. No. 11/417,658 and its prosecution history including the Office Action mailed Mar. 21, 2008, the amendment filed Sep. 18, 2008 and the following Prosecution Events: Office Actions: Dec. 17, 2008; Mar. 11, 2009; Jun. 3, 2009; Aug. 10, 2009; Nov. 10, 2009; Amendments: Mar. 17, 2009; Jul. 7, 2009.
  • 2007-0167901 prosecution history.
  • Alan S. Coulson, M.D., Jagjit Singh, M.D., Joseph C. Moya, “Modification of Venous End of Dialysis Grafts: An Attempt to Reduce Neointimal Hyperplasia,” Dialysis & Transplantation, vol. 29, No. 1, Jan. 2000, pp. 10 to 18.
  • A.S. Coulson, M.D., Ph.D, Judy Quarnstrom, I.V.N., J. Moshimia, M.D., “A Combination of the Elephant Trunk Anastomosis Technique and Vascular Clips for Dialysis Grafts,” Surgical Rounds, Nov. 1999, pp. 596 to 608.
  • International Search Report for PCT Application No. PCT/US98/01939 dated May 5, 1998 in 3 pages.
  • Search Report for EP Application No. 05006233.0 dated Jun. 8, 2005 in 2 pages.
  • The Office Action dated Dec. 17, 2008 issued in Co-Pending U.S. Appl. No. 11/417,658 in 11 pages.
  • The Amendment dated Mar. 17, 2009 filed in Co-Pending U.S. Appl. No. 11/417,658 in 12 pages.
  • Interview Summary dated Mar. 11, 2009 for Co-Pending U.S. Appl. No. 11/417,658 in 4 pages.
  • U.S. Appl. No. 10/219,998 including its prosecution history, Prosecution Events: Office Actions: Apr. 9, 2007; Oct. 7, 2008 Amendments: Sep. 10, 2007; Nov. 3, 2008; Jun. 16, 2009.
  • L.C. Koo Seen Lin et al., “Contemporary Vascular Access Surgery for Chronic Haemodialysis”, The Royal College of Surgeons of Edinburgh, J.R. Coll. Surg. Edinb., 41, Jun. 1996, 164-169.
  • Seshadri Raju, M.D., PTFE Grafts for Hemodialysis Access, “Techniques for Insertion and Management of Complications”, Ann. Surg. vol. 206, No. 5, Nov. 1987, pp. 666-673.
  • Anatole Besarab et al., “Measuring the Adequacy of Hemodialysis Access”, Current Opinion in Nephrology and Hypertension, Rapid Science Publishers ISSN 1062-4821, 1996, 5:527-531.
  • Melhem J.A. Sharafuddin, MD et al., Dialysis Access Intervention, “Percutaneous Balloon-assisted Aspiration Thrombectomy of Clotted Hemodialysis Access Grafts”, Journal of Vascular and Interventional Radiology, vol. 7, No. 2, Mar.-Apr. 1996, pp. 177-183.
  • David A. Kumpe et al., “Angioplasty/Thrombolytic Treatment of Failing and Failed Hemodialysis Access Sites: Comparison with Surgical Treatment”, Progress in Cardiovascular Diseases, vol. XXXIV, No. 4 (Jan./Feb.), 1992: pp. 263-278.
  • Robert Y. Kanterman, MD et al., Intervention Radiology, “Dialysis Access Grafts: Anatomic Location of Venous Stenosis and Results of Angioplasty”, Radiology Apr. 1995, vol. 195, No. 1, 195:135-139.
  • Clinical Review of MTI, Onyx® Liquid Embolization System, available at http://www.fda.gov/ohrms/dockets/ ac/03/briefing/3975b1-02-clinical-review.pdf , accessed Aug. 29, 2005.
Patent History
Patent number: RE44639
Type: Grant
Filed: Jan 15, 2010
Date of Patent: Dec 10, 2013
Assignee: Hemosphere, Inc. (Eden Prairie, MN)
Inventor: Rafael P. Squitieri (Wilton, CT)
Primary Examiner: Leslie Deak
Application Number: 12/688,716